Patient Assessment of Constipation Quality of Life
Patient Assessment of Constipation Quality of Life Questionnaire · Also known as: PAC-QoL, PAC-Q
The Patient Assessment of Constipation Quality of Life (PAC-QoL) is a validated, patient-reported outcome measure designed to assess the impact of functional constipation on physical, psychological, and social well-being. Developed by Marquis and colleagues in 2005, the PAC-QoL comprises 28 items organized into four domains: Physical Discomfort, Psychosocial Discomfort, Worries and Concerns, and Satisfaction. The PAC-QoL is responsive to treatment and widely used in constipation clinical trials and practice.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The PAC-QoL is indicated for patients with functional constipation requiring baseline quality-of-life assessment and ongoing monitoring of treatment response. It is used in clinical trials of laxatives, prokinetic agents, lubiprostone, linaclotide, and other constipation therapies to quantify the patient-centered benefit. In routine clinical practice, PAC-QoL is valuable at baseline to understand the burden of constipation beyond stool frequency (some patients have mild constipation with major quality-of-life impact; others have severe constipation with minimal impact). It is less useful in acute settings (obstruction, ileus) and is designed for chronic functional constipation, not secondary constipation (opioid-induced, medication-induced).
Strengths & limitations
- Patient-centered design: Derived from qualitative patient interviews; captures the domains most important to constipation sufferers, not just clinician priorities.
- Comprehensive construct coverage: Four subscales assess physical, psychological, and social impacts, providing a multidimensional picture of constipation burden.
- Responsiveness to treatment: PAC-QoL is highly responsive to constipation therapies; shows significant improvement with laxatives, linaclotide, and biofeedback therapy.
- Predictive validity: Baseline PAC-QoL predicts treatment response; patients with high baseline burden often derive greater absolute benefit from therapy.
- No objective constipation measure: PAC-QoL quantifies symptom burden and quality-of-life impact but does not measure colonic transit time or bowel movement frequency; correlation with objective measures is moderate (r ~0.4–0.6).
- Recall bias: 2-week recall period depends on patient memory; if a recent flare or remission occurs, the score may not reflect typical burden.
- Symptom-based only: Does not account for medication side effects, cost of treatment, or healthcare utilization burden.
- Limited discrimination at baseline: Many patients with functional constipation cluster near the upper end of the PAC-QoL scale (>3.5), limiting ceiling effects and ability to detect further worsening.
Frequently asked
Can PAC-QoL be used for opioid-induced constipation?
PAC-QoL can be used to assess quality-of-life burden in opioid-induced constipation, but it was validated in functional constipation. Consider administering PAC-QoL alongside opioid-specific constipation scales (e.g., OOAC scale) for comprehensive assessment. The underlying treatment approach differs (opioid antagonists vs. laxatives), so outcomes may differ from functional constipation trials.
How frequently should PAC-QoL be measured?
At baseline, establish PAC-QoL to quantify initial quality-of-life burden. After starting therapy, measure at 4–8 weeks to assess early response. In stable treatment, repeat every 3–6 months or if symptoms change. In clinical trials, PAC-QoL is typically measured every 2–4 weeks during the active treatment phase.
What if a patient has high PAC-QoL but normal bowel frequency?
This patient likely has functional constipation with preserved frequency but significant straining, bloating, or incomplete evacuation (normal-frequency constipation). PAC-QoL is sensitive to this phenotype. Alternatively, the patient may have IBS-C overlap or anxiety-predominant constipation. Investigate the specific symptoms driving the high PAC-QoL; tailor therapy to the predominant complaint.
Can I use individual PAC-QoL items instead of the full scale?
Not recommended. The PAC-QoL was validated as a 28-item scale with four subscales. Using individual items loses the dimensional structure and validated scoring. For brief assessment, use 2–3 representative items (e.g., 'How much discomfort do you experience from your constipation?' and 'How satisfied are you with your bowel function?') as a screening tool, but always administer the full PAC-QoL for comprehensive assessment.
Is there a PAC-QoL cutoff for severe constipation?
No fixed cutoff separates mild from severe constipation on PAC-QoL; severity is continuous. However, PAC-QoL >3.0 indicates significant burden warranting active treatment (not dietary fiber alone). PAC-QoL >3.5 indicates substantial burden and may predict poor response to first-line therapy; consider early escalation to secretagogues (linaclotide) or biofeedback.
Sources
- Marquis, P., De La Loge, C., Dubois, D., McDermott, A., & Chassany, O. (2005). Development and validation of the Patient Assessment of Constipation-Quality of Life questionnaire. Scandinavian Journal of Gastroenterology, 40(5), 540–551. DOI: 10.1080/00365520510012208 ↗
How to cite this page
ScholarGate. (2026, June 3). Patient Assessment of Constipation Quality of Life Questionnaire. ScholarGate. https://scholargate.app/en/gastroenterology/pac-qol
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gastroparesis Cardinal Symptom IndexGastroenterology↔ compare
- GERD Health-Related Quality of Life ScaleGastroenterology↔ compare
- Rome IV Irritable Bowel Syndrome CriteriaGastroenterology↔ compare
- Short Inflammatory Bowel Disease QuestionnaireGastroenterology↔ compare